/KASE, June 7, 2024/ – Black Biotechnology LLP (Almaty), whose bonds are
officially listed on Kazakhstan Stock Exchange (KASE), has provided KASE with
an auditor's report on the company's financial statements for 2023.
According to the audited data as of December 31, 2023
(in th. tenge, if not otherwise specified):
----------------------------------------
as of as of
Indicator 31.12.23 31.12.22
--------------------- --------- --------
Equity 7,583 -39,971
Total assets 1,965,079 117,378
Total liabilities 1,957,496 157,349
Sales volume 154,872 39,529
Gross margin 102,674 20,651
Net income (net loss) -13,668 -37,636
ROA, % -0.70 -32.06
ROE, % -180.25 94.16
ROS, % -8.83 -95.21
----------------------------------------
The company's financial statements for 2023 were audited by Audit company
"Solomon" LLP. According to the auditor's opinion, the financial statements
present fairly the financial position of Black Biotechnology LLP in all material
aspects as of December 31, 2023, as well as its financial results and cash flows
for the year ended as of the specified date in accordance with IFRS.
The report is available on KASE website at –
https://kase.kz/files/emitters/BKBT/bkbtf6_2023_rus.pdf
[2024-06-07]